Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added related topics Prostate cancer and MedlinePlus Genetics, and updated the page revision from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-01T17:54:57.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The changes are only revision numbers in the page footer (Revision: v3.3.1 added and v3.2.0 removed), with no modifications to the study details or other page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:53:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding disclaimer about operating status has been removed from the page. Core study content, eligibility criteria, and contacts appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:20:37.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Prostate cancer was removed as a topic on the page and MedlinePlus Genetics was removed from related topics. This reduces explicit topic labeling and related navigation for users.
    Difference
    0.6%
    Check dated 2025-11-03T01:24:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added topic tags: Prostate cancer and related topics: MedlinePlus Genetics. These additions appear in the page metadata/navigation and do not modify the trial details.
    Difference
    0.2%
    Check dated 2025-10-26T20:46:52.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and updated revision to v3.2.0; removed a MedlinePlus Genetics topic on Prostate cancer and old revision v3.1.0.
    Difference
    5%
    Check dated 2025-10-05T10:17:26.000Z thumbnail image

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.